Genome-based prediction of bacterial antibiotic resistance

M Su, SW Satola, TD Read - Journal of clinical microbiology, 2019 - Am Soc Microbiol
Clinical microbiology has long relied on growing bacteria in culture to determine
antimicrobial susceptibility profiles, but the use of whole-genome sequencing for antibiotic …

Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis

E Balsells, L Guillot, H Nair, MH Kyaw - PloS one, 2017 - journals.plos.org
Background Routine immunisation with pneumococcal conjugate vaccines (PCV7/10/13)
has reduced invasive pneumococcal disease (IPD) due to vaccine serotypes significantly …

Pivotal phase 3 randomized clinical trial of the safety, tolerability, and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults aged≥ 18 years

B Essink, C Sabharwal, K Cannon… - Clinical infectious …, 2022 - academic.oup.com
Abstract Background Pneumococcal conjugate vaccines (PCVs) have significantly reduced
pneumococcal disease, but disease from non-PCV serotypes remains. The safety …

Safety, tolerability, and immunogenicity of a 20-valent pneumococcal conjugate vaccine (PCV20) in adults 60 to 64 years of age

D Hurley, C Griffin, M Young Jr, DA Scott… - Clinical Infectious …, 2021 - academic.oup.com
Abstract Background Pneumococcal conjugate vaccines (PCVs) have significantly
decreased pneumococcal disease worldwide; however, expanding serotype coverage may …

Pneumococcal lineages associated with serotype replacement and antibiotic resistance in childhood invasive pneumococcal disease in the post-PCV13 era: an …

SW Lo, RA Gladstone, AJ Van Tonder… - The Lancet Infectious …, 2019 - thelancet.com
Background Invasive pneumococcal disease remains an important health priority owing to
increasing disease incidence caused by pneumococci expressing non-vaccine serotypes …

Biological and epidemiological features of antibiotic-resistant Streptococcus pneumoniae in pre-and post-conjugate vaccine eras: a United States perspective

L Kim, L McGee, S Tomczyk, B Beall - Clinical microbiology …, 2016 - Am Soc Microbiol
Streptococcus pneumoniae inflicts a huge disease burden as the leading cause of
community-acquired pneumonia and meningitis. Soon after mainstream antibiotic usage …

Development of Next Generation Streptococcus pneumoniae Vaccines Conferring Broad Protection

M Masomian, Z Ahmad, L Ti Gew, CL Poh - Vaccines, 2020 - mdpi.com
Streptococcus pneumoniae is a major pathogen causing pneumonia with over 2 million
deaths annually, especially in young children and the elderly. To date, at least 98 different …

Exploring bacterial diversity via a curated and searchable snapshot of archived DNA sequences

GA Blackwell, M Hunt, KM Malone, L Lima… - PLoS …, 2021 - journals.plos.org
The open sharing of genomic data provides an incredibly rich resource for the study of
bacterial evolution and function and even anthropogenic activities such as the widespread …

International genomic definition of pneumococcal lineages, to contextualise disease, antibiotic resistance and vaccine impact

RA Gladstone, SW Lo, JA Lees, NJ Croucher… - …, 2019 - thelancet.com
Background Pneumococcal conjugate vaccines have reduced the incidence of invasive
pneumococcal disease, caused by vaccine serotypes, but non-vaccine-serotypes remain a …

Pneumococcal within-host diversity during colonization, transmission and treatment

G Tonkin-Hill, C Ling, C Chaguza, SJ Salter… - Nature …, 2022 - nature.com
Characterizing the genetic diversity of pathogens within the host promises to greatly improve
surveillance and reconstruction of transmission chains. For bacteria, it also informs our …